Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

507 results about "Carnitine" patented technology

Carnitine (β-hydroxy-γ-N-trimethylaminobutyric acid, 3-hydroxy-4-N,N,N-trimethylaminobutyrate) is a quaternary ammonium compound involved in metabolism in most mammals, plants, and some bacteria. Carnitine may exist in two isomers, labeled D-carnitine and L-carnitine, which are both biologically active. At room temperature, pure carnitine is a white powder, and a water-soluble zwitterion with low toxicity. Carnitine only exists in animals as the L-enantiomer, and D-carnitine is toxic because it inhibits the activity of L-carnitine. Carnitine, derived from an amino acid, is found in nearly all organisms and animal tissue. Carnitine is the generic expression for a number of compounds that include L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. It is most accumulated in cardiac and skeletal muscles as it accounts for 0.1% of its dry matter. It was first derived from meat extracts in 1905, therefore the name carnitine is derived from Latin "carnus" or flesh. The body synthesizes enough carnitine from lysine side chains to keep up with the needs of energy production in the body as carnitine acts as a transporter of long-chain fatty acids into the mitochondria to be oxidized and produce energy. Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough, so this makes carnitine a conditionally essential nutrient for them.

Weight-losing and lipid-lowering health-care product and preparation method thereof

The invention relates to the technical field of health-care products, in particular to a weight-losing and lipid-lowering health-care product and a preparation method thereof. The weight-losing and lipid-lowering health-care product comprises chitosan, L-carnitine tartrate, polypeptide, a sweetening agent, an auxiliary protective agent and a filling agent. The invention also provides a preparation method of the composition. Compared with the prior art, the method has the advantages that the white kidney bean enzymatic hydrolysate, the trehalose and the plant extract are used as fermentation substrates for mixed fermentation, and the plant extract contains a large number of active ingredients which have the effect of promoting proliferation of probiotic strains and promoting fermentation, so that a large number of nutrient substances in the white kidney beans are dissolved out; further degrading into nutrient substances such as polypeptide, glucose, amino acid and the like which are easily absorbed by human beings; meanwhile, a large number of beneficial nutrition molecules are generated during mixed fermentation of the plant extract and the white kidney bean enzymatic hydrolysate, a large number of lipid-lowering substances can be generated, and meanwhile the good weight-losing effect is achieved.
Owner:JIANGI WENIR NUTRITION HIGH TECH

Oral instant film and preparation method thereof

The invention discloses an oral instant film suitable for pet nutrition intervention and a preparation method of the oral instant film, and belongs to the technical field of pet oral preparations. The instant film adopts a sandwich type multi-layer structural design, sequentially comprises a first food calling layer, a core layer and a second food calling layer, can be selectively provided with a functional layer and an interface middle layer, and constructs a staggered hot-pressing laminated structure, so that the structural stability and the function delivery efficiency of a film body are remarkably improved. The core layer contains multiple composite active ingredients such as L-carnitine, coenzyme Q10, beta-glucan, glucosamine sulfate and the like, chitosan-inulin-polyglutamic acid or starch is adopted for embedding to form a first microcapsule and a second microcapsule, and intelligent delivery of temperature / pH response and gastrointestinal controlled release is achieved. The food calling layer is composed of chicken powder, fish oil powder, fructo-oligosaccharide and the like, and the feeding compliance of pets is improved.
Owner:HUNAN SHANGCHENG BIOTECHNOLOGY CO LTD

Diglyceride oil powder for body weight management and preparation method thereof

The invention relates to the technical field of weight management, in particular to diglyceride oil powder for weight management and a preparation method of the diglyceride oil powder. The invention discloses diglyceride oil powder for weight management. The diglyceride oil powder comprises the following substances in parts by weight: 18-30 parts of flaxseed diglyceride; 10 to 20 parts of a konjak extract; 3 to 8 parts of L-carnitine; 3-8 parts of a white kidney bean extract; 2-5 parts of a green coffee extract; the flaxseed diglyceride is flaxseed diglyceride in which the sn-1, 3 structure proportion is greater than or equal to 85%. The multi-target body weight regulation network is constructed by taking flaxseed diglyceride as a core and combining the konjak extract, the L-carnitine, the white kidney bean extract and the green coffee extract. And a synergistic effect of'fat-carbon water double blocking + energy consumption 'is formed. The composition breaks through the action limitation of a single component by regulating and controlling full links of intake, absorption and metabolism.
Owner:TIMES FORMULAS FOR SPECIAL MEDICAL PURPOSES (SHENZHEN) CO LTD

Plasma metabolism diagnosis marker and diagnosis system for depression of children and adolescents

The invention relates to the technical field of diagnosis markers and diagnosis methods for mental diseases of children and adolescents, in particular to a plasma metabolism diagnosis marker and diagnosis system for depression of children and adolescents. The plasma metabolism diagnosis marker comprises at least one of cyclic adenosine monophosphate, methylpyridine, unsaturated undecylenyl carnitine, histidine, prolyl hydroxyproline, tryptophan and glucuronic acid. According to the scheme, non-target metabonomics data is analyzed, and seven candidate diagnostic markers for depression of children and adolescents are screened and determined from common differential metabolites. Then, through targeted metabonomics research, diagnostic markers and combinations thereof with ideal diagnostic effects are determined, and then a diagnostic model is constructed. And a sex factor is also incorporated into the diagnosis model, so that the diagnosis effect is further improved. According to the technical scheme, the technical problem that in the prior art, reliability and popularization potential of depression plasma metabolism biomarkers of children and adolescents are not ideal can be solved, and the depression plasma metabolism biomarkers have ideal popularization and application prospects.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY +1

MiRNA for regulating and controlling liver carnitine palmitoyltransferase I and application thereof

The invention discloses miRNA for regulating and controlling liver carnitine palmitoyl transferase I and application of the miRNA, and belongs to the field of molecular biology. According to the present invention, the existence of the binding site with the miR-380-3p in the CPT1A 3UTR region is clarified; experiments of transfecting miR-380-3p simulants and interferents by fetal sheep kidney medullary cells prove that the expression quantity of the CPT1A gene can be remarkably reduced at mRNA and protein levels through miR-380-3p overexpression, and the expression quantity of the CPT1A gene can be remarkably increased at the protein level through interference of endogenous miR-380-3p. Furthermore, the miR-380-3p provided by the invention can effectively regulate the expression of a target gene CPT1A, so that the miR-380-3p participates in influencing the metabolism of fatty acid, plays an important role in adapting the mongolian sheep to a cold environment in winter, and has application potential in the treatment of human obesity.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Sugar-controlling and fat-reducing composition for satiety as well as preparation method and application of sugar-controlling and fat-reducing composition

The invention discloses a satiety sugar-controlling fat-reducing composition and a preparation method and application thereof, the satiety sugar-controlling fat-reducing composition comprises hydrogel particles, a white kidney bean extract, a mulberry leaf extract, alpha-lipoic acid, L-carnitine, a lotus leaf extract, medium chain triglyceride, polyethylene glycol and sorbitol, and the composition is a tablet. The components are matched with one another to effectively adjust the leptin level, improve appetite, increase energy consumption, adjust the fat metabolism process, reduce fat accumulation, improve fat consumption, inhibit the activity of alpha-amylase, reduce the conversion of carbohydrates into fat, block heat and fat intake, promote gastrointestinal motility and enhance the immunity of the human body. The effects of remarkably reducing the fat content and the body weight are achieved.
Owner:SHANGHAI PANDA MEDICAL CO LTD +1

Biomarkers and use thereof for diagnosis, prevention, and treatment of muscle atrophy

There is provided a method for diagnosing a subject with early onset muscle atrophy, said method comprising: obtaining a biosample from the subject; and assaying the biosample for one or more biomarkers, said one more biomarkers are taurine, proline, citrulline, trigonelline, thymidine, ornithine, glutamate, L-pyroglutamic acid, creatinine, adenine, nicotinamide, 2-methylhippuric acid, maltol, L-arginine, hypotaurine, L-glutamine, homogentisic acid, methylhistidine, oxoglutaric acid, xanthine, L-carnitine, succinate, or a combination thereof; and identifying the subject with early onset muscle atrophy on the basis of a deviation in the one or more of said one more biomarkers.
Owner:MYOMAR MOLECULAR INC

A method for analyzing chiral impurities in L-carnitine key intermediate L-carnitine

The present invention belongs to the field of pharmaceutical chemical technology, and specifically relates to a method for analyzing chiral impurities of L-carnitine key intermediate L-carnitine. The method first uses (S)-2-(6-methoxy-2-naphthyl) propionyl chloride as a derivatization reagent to derive L-carnitine, and then uses high performance liquid chromatography to separate and detect the derivatized L-carnitine. The present invention proposes for the first time to use HPLC to determine the chiral purity of L-carnitine, which has simple steps and mild conditions, and is conducive to industrial promotion and application; the method of the present invention has strong specificity, high sensitivity, and good durability, and can be used for the accurate determination of the chiral purity of L-carnitine.
Owner:湖北楚维药业有限公司

Maturation medium compositions and methods for human heart organoid maturation

Provided herein are maturation media and methods for maturing early embryonic human cardiac organoids to mature human cardiac organoids. The maturation medium comprises a cell growth medium comprising a medium supplement comprising: one or more fatty acids, a triiodothyronine (T3) growth hormone, insulin, one or more antioxidants, a sugar, and carnitine; one or more additional fatty acids; additional carnitine or creatine; and a further T3 growth hormone. The maturation medium may also include one or more additional sugars, additional antioxidants, and growth factors. The methods include contacting an early embryonic human cardiac organoid with one or more maturation media to produce a mature human cardiac organoid.
Owner:BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIV

Hypoglycemic composition containing supramolecular group composite peptide and application of hypoglycemic composition in functional food and medicine

The invention discloses a hypoglycemic composition containing supramolecular group composite peptide. The hypoglycemic composition comprises collagen peptide, soybean peptide, bitter gourd peptide, bamboo leaf flavone, L-carnitine and the like. The composition prepared by selecting raw material components of specific types and dosages has the effects of remarkably reducing the glucose level and increasing the insulin level, and part of the composition can also cooperate with metformin to achieve the effects of enhancing the effect of reducing blood sugar and improving or preventing type 2 diabetes mellitus. Therefore, the method can be used for developing functional foods and medicines and has a considerable market prospect.
Owner:HANGZHOU HUANTE BIOLOGICAL TECH CO LTD

Nutritional composition for osteoporotic fracture recovery and preparation method thereof

The invention discloses a nutritional composition for osteoporotic fracture recovery and a preparation method thereof, and relates to the field of food / health care products. The composition for osteoporotic fracture recovery is prepared from the following components in parts by weight: 600 to 900 parts of oligomeric collagen peptide, 300 to 600 parts of small molecular oyster peptide, 100 to 300 parts of fish oil extract, 100 to 300 parts of calcium beta-hydroxy-beta-methyl butyrate, 100 to 150 parts of fructo-oligosaccharide, 60 to 90 parts of L-carnitine, 20 to 50 parts of gamma-aminobutyric acid, 10 to 30 parts of calcium aspartate and 3 to 4 parts of taurine. According to the composition for recovering the osteoporotic fracture, provided by the invention, a nutritional and healthy food suitable for recovering the osteoporotic fracture of the old people is formulated aiming at the conditions of constipation, chewing and swallowing conditions, mouth feel, compliance and the like of the osteoporotic fracture of the old people, especially bedridden patients, and various nutrients are combined according to a specific ratio; the traditional Chinese medicine composition is beneficial to accelerating body recovery of patients, preventing muscle attenuation, subsequently improving sclerotin and muscle strength for a long time, and reducing the risk of cardiovascular diseases at the same time.
Owner:ZHEJIANG MARINE DEVELOPMENT RESEARCH INSTITUTE

Feed premix for improving chicken quality

The invention provides a feed premix for improving chicken quality. The fresh-keeping agent is prepared from the following components in percentage by weight: 5%-15% of a flavor enhancing component, 10%-25% of a tenderness improving component, 3%-10% of an antioxidant fresh-keeping component, 2%-3% of a function enhancing component and the balance of a carrier and a diluent, the function strengthening component is prepared from beta-alanine embedded citronella essential oil and konjac glucomannan zymolyte; the flavor enhancing component comprises a rosemary extract, a yeast culture and curcumin in a mass ratio of (2-4): (1-3): 1; the tenderness improving component comprises conjugated linoleic acid, L-carnitine modified by glutamine transaminase and betaine in a mass ratio of (3-5): (2-4): 1; the antioxidant fresh-keeping component is vitamin E and tea polyphenol in a mass ratio of (1-2): 1. Through multi-component synergism and functional targeting optimization, a three-dimensional quality improvement system with enhanced flavor, improved tenderness, oxidation resistance and fresh keeping is constructed, so that the chicken quality is comprehensively upgraded.
Owner:BAIHE (SHANGHAI) BIOTECHNOLOGY CO LTD

Application of N-acetylglutamic acid in preparation of anti-myocardial fibrosis drugs

The invention relates to the field of biological medicines, and discloses application of N-acetylglutamic acid in preparation of anti-myocardial fibrosis medicines. According to the application disclosed by the invention, the N-acetylglutamic acid and the carglutamic acid are found to have the effects of obviously improving the systolic function of the heart, reducing the energy metabolism deposition of the fibroblasts and reducing the collagen deposition so as to inhibit excessive fibrosis of the myocardial fibroblasts after myocardial infarction for the first time. The discovery provides a'switch 'for fibroblast repair of myocardial infarction and excessive fibrosis, and has important value for avoiding the excessive fibrosis of the heart after myocardial infarction.
Owner:ZHEJIANG UNIV

L-carnitine composite tablet with high hygroscopicity resistance and preparation method of L-carnitine composite tablet

The invention discloses an L-carnitine composite tablet with high hygroscopicity resistance and a preparation method of the L-carnitine composite tablet. The preparation method comprises the following steps: S1, adding 65-80 parts by weight of dietary fiber, 1-3 parts by weight of tea polyphenol, 5-10 parts by weight of isomaltitol, 1-3 parts by weight of calcium carbonate and 0.75-1.5 parts by weight of hydroxypropyl methylcellulose into a boiling drying granulator, and mixing to obtain mixed powder; s2, uniformly spraying a citric acid solution on the surface of the mixed powder in a guniting manner to obtain a first guniting material; s3, uniformly spraying an L-carnitine solution on the surface of the first guniting material in a guniting manner, so that L-carnitine is uniformly absorbed in pores of dietary fibers and honeycomb-shaped pores generated by citric acid and calcium carbonate to obtain a second guniting material; and S4, carrying out guniting granulation by utilizing 0.25-0.5 part of a hydroxypropyl methylcellulose solution, adding 2-3 parts by weight of a lubricant and an anti-caking agent after granulation is completed, uniformly mixing to obtain a total mixed material, tabletting, and coating to obtain the L-carnitine composite tablet.
Owner:BAOJIAN (BEIJING) BIOTECHNOLOGY CO LTD

Compound amino acid composition for enhancing telomerase activity and preparation method thereof

The invention relates to the technical field of amino acid compositions, and discloses a compound amino acid composition for enhancing telomerase activity, which comprises the following components (by weight): 20-25 parts of L-arginine; 15 to 20 parts of L-lysine; 25 to 30 parts of L-glutamine; 10 to 15 parts of L-serine; 5 to 8 parts of L-glycine; 3 to 5 parts of L-proline; 2 to 4 parts of N-acetyl-L-cysteine; 1 to 2 parts of L-tryptophan; 1 to 2 parts of beta-alanine; 2 to 3 parts of L-carnitine; 1-2 parts of taurine; through the synergistic effect of multiple mechanisms, the compound amino acid composition not only significantly enhances the telomerase activity (up to 195%), but also can maintain the telomere length, inhibit cell aging and provide antioxidant protection. The comprehensive regulation effect is derived from a unique metabolic network formed among the components, and mutual promotion and regulation are realized. Experimental results show that the long telomere length (8.3 kb vs control group 7.1 kb) can be maintained in 30-day long-term culture.
Owner:ZHANGSHU YIKANG PHARM CO LTD

Method for constructing serum endogenous biomarkers of patients with depression and depression diagnosis model

The invention discloses a method for constructing a blood serum endogenous biomarker and a depression diagnosis model of a depression patient, which couples non-targeting and targeting screening technologies, systematically characterizes endogenous small molecule metabolites in blood serum, identifies differential metabolites between the depression patient and a healthy control group, and determines the blood serum endogenous biomarker and the depression diagnosis model of the depression patient. And then determining a biomarker closely related to depression by using a regression model. According to the invention, potential depression biomarkers such as N-methyl-L-alanine, N-acetylneuraminic acid, N-acetylglycine, thymine ribonucleoside, decanoyl carnitine, aspartic acid-phenylalanine and the like are discovered. The diagnosis model obtained by training according to the ratio of N-acetylglycine to thymine ribonucleoside has the highest accuracy (99%), and healthy and disease samples can be effectively distinguished by using a threshold value 2.434. Therefore, the ratio of N-acetylglycine to thymine ribonucleoside is a potential biomarker capable of realizing rapid and accurate diagnosis of depression.
Owner:SOUTH CHINA INST OF ENVIRONMENTAL SCI MEP

Technology development and application of new special medical food based on new food raw material framework

The invention relates to technical development and application of new special medical food on the basis of a new food raw material framework, and belongs to the technical field of special medical purpose formula food (FSMP). According to the series of foods, new food raw materials (euglena, haematococcus pluvialis and ampelopsis grossedentata leaves) are taken as cores, medicinal and edible components (lotus leaves, haws and mulberry leaves) and marine active substances (fucoidan polysaccharides and chitin) are combined, functional factors are extracted through a prehydrolysis SBE technology and a biological enzymolysis technology, and the bioavailability is improved by adopting a nano-carrier technology. The product comprises a total nutrient base material (20-30% of protein and 15-25% of dietary fiber), functional components (10-15% of a new food raw material extract and 8-12% of a traditional Chinese medicine extract) and a metabolism regulator (conjugated linoleic acid and L-carnitine). Clinical tests show that after an obese patient takes 400 kcal of the replacement meal every day, the weight of the obese patient is reduced by 10.2 kg on average (4.8 kg of a control group) 12 weeks later, and the body fat rate is reduced by 16.3%. The product supports line iteration (such as powder, tablets and liquid food) through modular formula design, and fills the application blank of new food raw materials in special medical food.
Owner:SHANXI TONGWEN VOCATIONAL & TECHNICAL COLLEGE

A meal replacement powder for weight loss in obese patients and a method for preparing the same

The application belongs to the technical field of functional food, and particularly discloses a meal replacement powder for weight loss of obese patients and a preparation method thereof. The meal replacement powder comprises whey protein powder, composite dietary fiber (containing at least two kinds of konjac powder and the like), functional carbohydrate, functional fat (containing medium-chain fatty acid and the like), and composite vitamins, minerals, functional additives (L-carnitine and the like), and stability additives. The preparation comprises raw material pretreatment, small material premixing, large material mixing, microencapsulation of fat-soluble components, total mixing, sterilization and packaging, and the key lies in that the fat-soluble components are wrapped by wall materials and spray dried into microcapsules. The meal replacement powder can balance nutrition, strengthen satiety, promote fat metabolism, avoid muscle loss and electrolyte imbalance, has a shelf life of 12 months at room temperature, has good palatability, has good weight loss effect (average weight loss of 5.8 kg in 2 months), has no adverse reactions, and is suitable for long-term weight loss diet management of obese patients.
Owner:石霞

Uses of engineered yeast strains and lipid compositions thereof

PCT designated stageWO2025212524A1Organic active ingredientsDigestive systemMonoglycerideCellular Aging
Provided herein are methods and materials for using organisms (e.g., engineered yeast strain-derived) to generate lipid compositions which can modulate cellular aging, extend lifespan, and / or modulate gut homeostasis in a subject. The lipid compositions contain at least twelve of the lipids selected from a phosphatidylethanolamine (PE); a lysophosphatidylethanolamine (LPE); a diacylglycerol (DG); a monoglyceride (MG); an acyl carnitine (AcCa); a phosphatidic acid (PA); a phosphatidylglycerol (PG); a lysophosphatidylcholine (LPC); a triacylglycerol (TG); a cholesterol ester (ChE); a wax ester (WE); a phosphatidylserine (PS); a phosphatidylcholine (PC); a phosphatidylinositol (PI); a ceramide (Cer); and a lysophosphatidylserine (LPS).
Owner:RGT UNIV OF CALIFORNIA

Enzyme mutant, enzyme composition or immobilized enzyme thereof, and application and method for preparing L-L-carnitine

The invention relates to the field of enzyme engineering, in particular to an enzyme mutant, an enzyme composition or an immobilized enzyme thereof, and application and a method for preparing L-L-carnitine by using the enzyme mutant and the enzyme composition or the immobilized enzyme thereof. The invention provides a simple process for preparing L-carnitine by a whole enzyme method, which is characterized in that bulk betaine (N, N, N-trimethylglycine) and acetic acid are used as raw materials in the whole process. L-carnitine is directly obtained through two-step continuous conversion of carboxyl reductase (CAR) and aldolase (DERA). The route can be completed in one step by utilizing crude enzyme liquid, recyclable immobilized enzyme can also be utilized, and reduced coenzyme II (NADPH) and adenosine triphosphate (ATP) which are used in the first step of reaction can also be recycled by utilizing corresponding enzyme, so that the production cost is further reduced. Therefore, the process for preparing the L-carnitine has the advantages of being completely green, simple in process, low in production cost, easy for large-scale production and the like.
Owner:SOUTH CHINA NORMAL UNIV

Energy-controlling liquid nutritional composition and preparation method thereof

The invention belongs to the technical field of special meal liquid nutrition, and discloses an energy-controlled liquid nutrition composition and a preparation method thereof, the energy-controlled liquid nutrition composition comprises the following components by mass: 2-10 parts of milk-derived protein, 0-3 parts of peptide, 3-12 parts of a carbohydrate raw material, 0.5-5 parts of vegetable oil, and 0.1-6 parts of a dietary fiber raw material; 0.05 to 0.5 part of vitamin premix, 0 to 0.1 part of mineral premix and 0 to 0.8 part of L-carnitine; 0.05-2 parts of an emulsifying agent, 0.01-1 part of a thickening agent, 0.05-1 part of a pH regulator, 0-0.1 part of a sweetening agent, 0-1 part of a flavor substance and the balance of water, and the total amount of the components is 100 parts. Through an emulsification technology and a complex nutrition system stabilization technology, the prepared liquid milk energy-control meal replacement product does not need to be brewed and can be drunk after a bottle and a bag are opened. The pH value of the prepared nanoscale emulsion product is neutral or nearly neutral, so that the high-quality milk-derived protein is stably applied, and the phenomena of precipitation, layering, fat floating and the like are avoided.
Owner:GOUJIAN NUTRITIONAL MEDICINE TECH (BEIJING) CO LTD

Pre-eclampsia risk assessment and prediction model based on metabonomics and application thereof

The invention provides a metabonomics-based preeclampsia risk assessment prediction model construction method, a prediction model, application of metabolites, a metabolite detection kit, a prediction product, a prediction system and related application thereof. Specifically, clinical indexes and metabolite data of a pregnant woman serve as input, whether the pregnant woman suffers from preeclampsia or not serves as output, model construction is conducted through a machine learning method, and a preeclampsia risk assessment and prediction model is obtained. The metabolite is selected from at least one of 4-hydroxyphenyllactic acid, homovanillic acid, ornithine, sarcosine, adenosine monophosphate and 3-methylbutyryl carnitine. According to the invention, not only are six metabolite markers strongly associated with preeclampsia found, but also effective prediction of early preeclampsia and late preeclampsia is realized by establishing a prediction model, and the method has extremely high clinical value.
Owner:BGI GENOMICS CO LTD

Hydrogel for body weight management

PCT designated stage expiredWO2025108566A1Metabolism disorderFood scienceBody weightBiology
A hydrogel comprising sodium carboxymethylcellulose cross-linked with a mixture of citric acid and a second cross-linker, selected from a standard amino acid, L-carnitine, N,N,N-trimethylglycine and choline and a pharmaceutically acceptable choline salt, a process for the production of the hydrogel, and its use in the body weight management.
Owner:CLOUDPHARM PRIVATE CO

Preparation process of effervescent tablets containing L-carnitine tartrate

The invention discloses a preparation process of an effervescent tablet containing L-carnitine tartrate, comprising: a main body unit comprising a tank body, the top of the tank body being fixed and communicated with a charging barrel, the bottom of the tank body being provided with a discharge port, the inner wall of the bottom of the charging barrel being fixed with a partition plate, the partition plate being internally provided with a plurality of discharge holes at equal intervals, and a baffle plate being arranged below the partition plate, a control assembly for controlling the baffle to move is arranged at the top of the tank body. When the rectangular plate rotates, due to the fact that the width of the air making opening is gradually reduced in the direction from the weight block to the rectangular plate, when air passes through the air making opening, the air flow speed is increased, the air speed is increased, when the air passes through the air inlet, the air is heated by the heating rod, and annular waterfall-shaped powder raw materials can be blown and dried; and in the process of blowing the powder raw materials into the space, the powder raw materials are blown away, that is, powder raw material particles are separated from one another, so that hot air can more sufficiently dry the powder raw materials.
Owner:JIANGSU HANDIAN BIOTECHNOLOGY CO LTD

Anti-aging capsule compounded by PQQ and mitochondrial nutrients

The invention relates to an anti-aging capsule compounded by PQQ and mitochondrial nutrients, and discloses an anti-aging capsule which is prepared by synergistically compounding a plurality of mitochondrial nutrients according to a scientific proportion and supplementing high-purity raw materials and slow-release dosage forms to realize energy metabolism activation and anti-oxidation synergistic intervention. Therefore, the anti-aging capsule systematically delays aging through multi-target regulation and control of mitochondrial functions. The capsule is characterized by comprising the following components in parts by weight: 1-20 mg of pyrroloquinoline quinone disodium salt (PQQ), 20-100 mg of coenzyme Q10, 50-200 mg of L-carnitine tartrate, 10-100 mg of alpha-lipoic acid, 50-300 mg of nicotinamide mononucleotide (NMN) or nicotinamide nucleoside (NR), and 10-50 [mu] g of selenoprotein or organic selenium yeast, and a capsule carrier comprises 100 mg of gelatin or a plant-derived capsule shell, 180 mg of microcrystalline cellulose, 5 mg of magnesium stearate and 5 mg of silicon dioxide.
Owner:JIANGSU SHAREJOY HEALTH TECH CO LTD

Modified milk powder for children as well as preparation method and application of modified milk powder

The invention provides modified milk powder for children as well as a preparation method and application thereof, and relates to the field of modified milk powder. The formula of the modified milk powder comprises skimmed milk powder, demineralized whey powder, whole milk powder, lactose, isomaltooligosacharide, crystalline fructose, vegetable oil, composite vitamins, composite minerals, calcium carbonate, choline chloride, L-carnitine, L-lysine, hydrolyzed yolk powder, soda water, lactoferrin, docosahexaenoic acid and probiotics. A finished product is obtained through the steps of burdening, shearing and filtering, homogenizing, sterilizing, concentrating, spray drying, bean jelly, dry mixing and the like. According to the modified milk powder, various trace elements can be supplemented by adding soda water; in addition, addition of soda water, hydrolyzed yolk powder or isomaltooligosacharide can promote absorption of calcium by the body and promote skeletal development of children.
Owner:YOUBEI NUTRITION TECHNOLOGY (SHENYANG) CO LTD

Gout damp-heat syndrome subtype modeling method, application of biomarker group and detection method

The invention belongs to the technical field of animal model analysis, and particularly relates to a modeling method of a gout damp-heat syndrome subtype model, application of a biomarker group and a detection method. According to the invention, two subtype models of pain, rheumatism and severer heat and severer heat are constructed, a UPLC-MS (Ultra Performance Liquid Chromatography-Mass Spectrometry) detection method of serum biomarkers is established, and a biomarker group comprising lauroyl carnitine, taurocholic acid, palmitoyl-L-carnitine, L-leucine, leukotriene A4, 13-Oxo-9 and 11-tridecioic acid is obtained. Researches show that the biomarker group can simply and effectively distinguish models of pain and rheumatism heavier than heat and models of heat heavier than wet and judge whether modeling of two subtypes succeeds or not, so that the biomarker group can replace conventional characterization and biochemical pathology evaluation methods, and the objectivity and operability of judgment are improved.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Metabolic marker for screening and evaluating lung cancer risk and application thereof

The invention discloses a metabolic marker for screening and evaluating the risk of lung cancer and application thereof, and belongs to the technical field of biological medicine, the metabolic marker is selected from amino acid, carbohydrate, cofactor and vitamin, energy metabolite, lipid, nucleotide, peptide and allobiomass, and the like. The kit particularly comprises a group consisting of 1-linoleoyl phosphatidyl ethanolamine, fibrinogen splitting peptide with a sequence of ADPSGEGDFXAEGGGVR, isovaleryl carnitine, oleic acid, 1-arachidonyl phosphatidylcholine, arachidonic acid, acetyl phosphoric acid, ergothioneine, isoleucine and metoprolol acid, and is used for preparing a detection product, such as a kit, for screening and evaluating the risk of lung cancer. Through accurate detection and analysis of metabolic markers, the accuracy and efficiency of early diagnosis of lung cancer can be improved, and a new scientific basis is provided for future lung cancer prevention, treatment and personalized medical treatment.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV